Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms 3, 2-(2-(dimethylaminomethyl)phenoxy)-5-iodophenylamine |
Target |
Action modulators, enhancers |
Mechanism SERT modulators(Serotonin transporter modulators), SPECT(Single-photon emission-computed tomography enhancers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Depressive Disorder | Preclinical | United States | 03 Sep 2004 |





